Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs-Reference-Cited by-同舟云学术

Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs

Published:2017-09 Issue: Volume:8 Page:211-219
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Matsuzono Kosuke,Imamura Keiko,Murakami Nagahisa,Tsukita Kayoko,Yamamoto Takuya,Izumi Yuishin,Kaji Ryuji,Ohta Yasuyuki,Yamashita Toru,Abe Koji,Inoue Haruhisa

Funder

Program for Intractable Diseases Research

Japan Agency for Medical Research and Development

AMED

Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine

Research Project for Practical Applications of Regenerative Medicine

The Daiichi Sankyo Foundation of Life Science

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference45 articles.

1. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement;Kobayashi;Am. J. Hum. Genet.,2011

2. ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization;García-Murias;Brain,2012

3. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion;Obayashi;J. Neurol. Neurosurg. Psychiatry,2015

4. Genetic and clinical analysis of spinocerebellar ataxia type 36 in Mainland China;Zeng;Clin. Genet.,2016

5. Spinocerebellar ataxia type 36 in the Han Chinese;Lee;Neurol. Genet.,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexanucleotide repeat expansion in SCA36 reduces the expression of genes involved in ribosome biosynthesis and protein translation;Journal of Human Genetics;2024-05-29

2. Treatability of the KMT2-Associated Neurodevelopmental Disorders Using Antisense Oligonucleotide-Based Treatments;Human Mutation;2024-05-29

3. Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?;Cells;2024-02-09

4. Ataxia and motor neuron disease;A Review on Diverse Neurological Disorders;2024

5. Phenotype and management of neurologic intronic repeat disorders (NIRDs);Revue Neurologique;2023-03